Joined in 2023 
82 
63 About this deal
Vaccine MAP developers are entering new territory with respect to manufacturing processes, capability, and infrastructure. Advanced pilot manufacturing runs will be required to demonstrate to, and assure, key players in the vaccine industry that a new vaccine MAP platform will be cost-effective to manufacture at scale compared with the existing well-established N&S.
An overview of microneedle applications, materials, and
The major difference between microneedling and microneedle patches is that microneedle patches cannot harm the skin and cause injury. Help! How Do I Decide Which Ones Are Best for Me? Interstitial fluid (ISF)—compared with other peripheral biofluids such as saliva, sweat and tears—is a particularly rich source of soluble bioanalytes including proteins, peptides, metabolites and nucleic acids that exhibits close correlation with blood 1, 2, 3, 4, 5, 6. It also represents the locoregional biomolecular composition of specific tissues of interest, such as within the tumour microenvironment 7. Simple and effective methods that enable comprehensive analysis of ISF can lead to transformative advances in biodiagnostic technologies that are not only minimally invasive and pain free, but also ideally suited for point-of-care and resource-limited settings 8, 9, 10. Extraction of ISF followed by ex vivo analysis 11 has not been widely embraced in preclinical or clinical applications, largely because of (1) difficulty in extracting ISF, which is time consuming and requires bulky instruments 12, 13, 14 and (2) the small amount of ISF that can be extracted using current technology, making comprehensive analysis challenging 15. For example, microneedle-assisted extraction of ISF yields about 2 μl of biofluid from 4 cm 2 of human skin even after 20 min of vacuum suction, which is insufficient for comprehensive proteomic and metabolomic analysis 15. Indeed, in preclinical settings (for example, when using small animal models), to measure the concentration of target biomarkers, it is common to pool ISF from multiple subjects to obtain sufficient material, which inevitably masks the subject-to-subject biological variability 16. Demonstration of dose-sparing, and the safety and acceptability of HD-MAPs in human populations, combined with demonstration of the scalability of manufacturing and potentially lower cost of goods compared with prefilled N&S, should accelerate the adoption of HD-MAP technology by vaccine manufacturers and funding by global health partners. McHugh and former visiting scientist Lihong Jing are the lead authors of the study, which appears today in Science Translational Medicine. Ana Jaklenec, a research scientist at MIT’s Koch Institute for Integrative Cancer Research, and Robert Langer, the David H. Koch Institute Professor at MIT, are the senior authors of the paper.Two or three doses of standalone IPV or combined IRV-IPV in the first-generation dMNP at full or half dose induced protective titers (≥1:8) of NA to the corresponding PV types 1, 2, and 3 in rats (Fig. 5d–f). The differences in antibody titer between post-vaccine doses 2 and 3 of full dose standalone IPV and full IRV-IPV were not statistically significant. Similarly, the differences in antibody titer between post-vaccine doses 2 and 3 of full-dose IPV, full-dose IRV-IPV, and half-dose IPV or half-dose IRV-IPV were not statistically significant. Of the three IPV types, IPV 2 was the most immunogenic and induced high geometric mean titers (GMTs) to PV type 2 even with a single dose. Now, engineers have come out with the offer to make as many of a relatively new and efficient type of drug/vaccine delivery systems as are needed for research on vaccine development and the treatment of this condition to continue. The technology – microneedle arrays It is hoped that the patches, which are described in the journal Biomaterials Advances, will be ready for use within the next five to 10 years. Moon, SS., Richter-Roche, M., Resch, T.K. et al. Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine.
PATCH PRO MICRO NEEDLE PATCH 8pcs, self-dissolving PATCH PRO MICRO NEEDLE PATCH 8pcs, self-dissolving
Although there are no vaccines delivered by microneedle patches on the market, there are nonmedical applications for sale. Cosmetic companies sell microneedle patches that promise to smooth skin and remove wrinkles.Mark Prausnitz, Georgia Tech Regents' professor in the School of Chemical and Biomolecular Engineering, holds a vaccine patch containing microneedles that dissolve into the skin. Microneedle patches work by dissolving active ingredients into the skin. Therefore, to use the most effective ones, look for microneedle patches that contain the best active ingredients such as collagen, peptides, hyaluronic acid, and salicylic acid and contain a high number of microscopic needles. What Does a Microneedle Patch Do for Fine Lines and Wrinkles?
Great Deal 
New Comment